Tenax Therapeutics is trading at $2.13, up +7.58%, on renewed investor interest ahead of its September 9, 2026 Cantor Global Healthcare Conference presentation.
- CEO Chris Giordano is scheduled to present at 8:35 a.m. ET.
- ADAR1 Capital Management increased its stake to approximately 15%, supporting confidence in the company.
- The broader market is modestly lower, making the gain primarily company-specific.